RESUMO
Mycobacterium abscessus is a rapidly growing species of environmental mycobacteria commonly found in soil, dust, and water throughout the world. In immunocompetent patients, M. abscessus usually causes localized infection of skin and soft tissue in association with a traumatic or surgical wound. Although rare, it may cause disseminated systemic infection in patients with HIV, diabetes, or medically induced immunosuppression. Here we report a case of a 53-year-old female patient with disseminated skin and soft tissue infection due to M. abscessus who presented with multiple skin lesions on the trunk, back and four extremities. The patient had undergone salvage chemotherapy, modified radical mastectomy, and palliative chemotherapy for metastatic breast cancer. Granulomatous inflammation and acid-fast bacilli were found on skin biopsy. M. abscessus was identified via mycobacterial culture and PCR-restriction fragment length polymorphism analysis. The patient responded well to clarithromycin, cefoxitin and amikacin therapy, and was subsequently discharged on oral antimicrobial therapy. Non-tuberculous mycobacterial (NTM) infection is a rare cause of skin and soft tissue infection, and a very high index of suspicion is required to initiate an evaluation for NTM. In metastatic cancer patients with multiple skin lesions, skin infection due to NTM must be differentiated not only from cutaneous metastasis but also from bacterial or fungal infection.
Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Amicacina , Biópsia , Mama , Neoplasias da Mama , Cefoxitina , Claritromicina , Poeira , Extremidades , HIV , Terapia de Imunossupressão , Inflamação , Mastectomia Radical Modificada , Mycobacterium , Infecções por Mycobacterium não Tuberculosas , Metástase Neoplásica , Pele , Infecções dos Tecidos Moles , SoloRESUMO
Avian mycobacteriosis is important for animal and human health; wild birds play an important role in mycobacterial species' ecology and movement. This review was aimed at reporting the role of birds in the spread of avian mycobacteriosis in human and animal populations at risk and thus a systematic review was made of PubMed, Science Direct, Scielo and Scirus databases. Mycobacteria are classified into the Mycobacterium tuberculosis complex and non-tuberculous mycobacteria; the Mycobacterium avium complex represents the most important part of the latter because it is primarily responsible for mycobacterial infection in wild birds and is a potential pathogen for mammals, especially for immunocompromised patients. The clinical signs in birds are variable as it is a chronic and debilitating disease, involving emaciated carcasses, white nodules in different organs and microscopically it presents granulomatosous multifocal inflammation. Diagnosis begins by suspicion based on clinical signs and finishes with microbiological confirmation. New diagnostic techniques include testing with DNA-RNA probes. No effective treatment is currently available and chemoprophylaxis on suspicion of infection is not recommended at the start; these factors increase the potential risk of mycobacteriosis becoming one of the most frequently documented zoonotic diseases which is difficult to treat in birds and humans. Recent concern regarding mycobacterial infection lies in the increased frequency of these opportunistic infections occurring in immunocompromised individuals and these infections' potential impact on bird conservation, this being increased by greater contact between humans and wild and captive birds.
La micobacteriosis aviar es de importancia para la salud animal y humana. El objetivo de esta revisión fue reportar el papel de las aves en la diseminación de la micobacteriosis aviar en poblaciones vulnerables. Se realizó una revisión sistemática en las bases de datos PubMed, Science Direct, Scielo and Scirus. Las aves silvestres juegan un papel importante en la ecología y movimiento de micobacterias. Estas se clasifican en el Complejo Mycobacterium tuberculosis y las micobacterias no tuberculosas, dentro de este último grupo se destaca el Complejo Mycobacterium avium , principal responsable de micobacteriosis en aves silvestres y patógeno potencial para los mamíferos principalmente pacientes inmunosuprimidos. Los signos clínicos son variables, siendo una enfermedad debilitante y crónica, e involucra carcasas emaciadas, nódulos blanquecinos en diferentes órganos, microscópicamente presenta inflamaciones granulomatosas multifocales. El diagnóstico inicia por la sospecha basada en los síntomas clínicos y termina con la confirmación microbiológica. Adicionalmente, las nuevas técnicas diagnósticas incluyen pruebas con sondas de ADN-ARN. Actualmente, no existe un tratamiento efectivo y no se recomienda iniciar quimioprofilaxis; estos factores incrementan el riesgo potencial para convertir la micobacteriosis aviar en una enfermedad zoonótica más frecuente de lo documentado y de difícil tratamiento en aves y humanos. La reciente preocupación de las infecciones micobacterianas, radica en el aumento de la frecuencia de estas infecciones oportunistas en personas inmunocomprometidas y el impacto potencial de estas infecciones sobre la conservación de las especies de aves, favorecido por el mayor contacto entre humanos y aves tanto silvestres como cautivas.